• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用药物和非药物治疗对精神分裂症症状进行整体管理。

Holistic Management of Schizophrenia Symptoms Using Pharmacological and Non-pharmacological Treatment.

作者信息

Ganguly Pronab, Soliman Abdrabo, Moustafa Ahmed A

机构信息

School of Social Sciences and Psychology, Western Sydney University, Sydney, NSW, Australia.

Department of Social Sciences, College of Arts and Sciences, Qatar University, Doha, Qatar.

出版信息

Front Public Health. 2018 Jun 7;6:166. doi: 10.3389/fpubh.2018.00166. eCollection 2018.

DOI:10.3389/fpubh.2018.00166
PMID:29930935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5999799/
Abstract

Individuals with schizophrenia lead a poor quality of life, due to poor medical attention, homelessness, unemployment, financial constraints, lack of education, and poor social skills. Thus, a review of factors associated with the holistic management of schizophrenia is of paramount importance. The objective of this review is to improve the quality of life of individuals with schizophrenia, by addressing the factors related to the needs of the patients and present them in a unified manner. Although medications play a role, other factors that lead to a successful holistic management of schizophrenia include addressing the following: financial management, independent community living, independent living skill, relationship, friendship, entertainment, regular exercise for weight gained due to medication administration, co-morbid health issues, and day-care programmes for independent living. This review discusses the relationship between different symptoms and problems individuals with schizophrenia face (e.g., homelessness and unemployment), and how these can be managed using pharmacological and non-pharmacological methods. Thus, the target of this review is the carers of individuals with schizophrenia, public health managers, counselors, case workers, psychiatrists, and clinical psychologists aiming to enhance the quality of life of individuals with schizophrenia.

摘要

精神分裂症患者的生活质量较差,原因包括医疗护理不足、无家可归、失业、经济拮据、缺乏教育以及社交技能欠佳。因此,对与精神分裂症整体管理相关的因素进行综述至关重要。本综述的目的是通过解决与患者需求相关的因素并以统一的方式呈现这些因素,来提高精神分裂症患者的生活质量。尽管药物治疗发挥着作用,但导致精神分裂症成功整体管理的其他因素包括解决以下方面:财务管理、独立社区生活、独立生活技能、人际关系、友谊、娱乐、针对因药物治疗导致体重增加的定期锻炼、共病健康问题以及独立生活日托项目。本综述讨论了精神分裂症患者面临的不同症状和问题(如无家可归和失业)之间的关系,以及如何使用药物和非药物方法来管理这些问题。因此,本综述的目标受众是精神分裂症患者的护理人员、公共卫生管理人员、咨询师、个案工作者、精神科医生以及旨在提高精神分裂症患者生活质量的临床心理学家。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19c/5999799/847876468171/fpubh-06-00166-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19c/5999799/847876468171/fpubh-06-00166-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19c/5999799/847876468171/fpubh-06-00166-g0001.jpg

相似文献

1
Holistic Management of Schizophrenia Symptoms Using Pharmacological and Non-pharmacological Treatment.使用药物和非药物治疗对精神分裂症症状进行整体管理。
Front Public Health. 2018 Jun 7;6:166. doi: 10.3389/fpubh.2018.00166. eCollection 2018.
2
Schizophrenia through the carers' eyes: results of a European cross-sectional survey.从护理人员视角看精神分裂症:一项欧洲横断面调查结果
J Psychiatr Ment Health Nurs. 2015 Sep;22(7):472-83. doi: 10.1111/jpm.12209. Epub 2015 May 6.
3
Effect of Community-Based Social Skills Training and Tai-Chi Exercise on Outcomes in Patients with Chronic Schizophrenia: A Randomized, One-Year Study.基于社区的社交技能训练和太极拳锻炼对慢性精神分裂症患者预后的影响:一项为期一年的随机研究。
Psychopathology. 2016;49(5):345-355. doi: 10.1159/000448195. Epub 2016 Sep 2.
4
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].[制定重症精神疾病患者身体健康检查指南]
Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9.
5
The importance of psychosocial interventions and patient involvement in the treatment of schizophrenia.精神分裂症治疗中社会心理干预和患者参与的重要性。
Int J Psychiatry Clin Pract. 2000;4(1):35-51. doi: 10.1080/13651500050518028.
6
Running for your life: A review of physical activity and cardiovascular disease risk reduction in individuals with schizophrenia.为生命而奔跑:精神分裂症患者体育活动与心血管疾病风险降低的综述
J Sports Sci. 2016 Aug;34(16):1500-15. doi: 10.1080/02640414.2015.1119875. Epub 2015 Dec 2.
7
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.促进和支持社区中患有慢性身体疾病的成年人进行自我管理:对医患互动的有效性和意义的系统评价。
JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001.
8
[Advocacy for the establishment of a comprehensive strategy to reduce the "burden" of schizophrenic disorders].倡导制定一项全面战略以减轻精神分裂症谱系障碍的“负担”
Encephale. 2016 Oct;42(5):476-483. doi: 10.1016/j.encep.2016.05.007. Epub 2016 Sep 9.
9
Quality of life of clients with schizophrenia.精神分裂症患者的生活质量。
J Adv Nurs. 2004 Jan;45(1):72-83. doi: 10.1046/j.1365-2648.2003.02863.x.
10
[Evolution of the social autonomy scale (EAS) in schizophrenic patients depending on their management].[精神分裂症患者社会自主量表(EAS)根据其管理方式的演变]
Encephale. 2010 Oct;36(5):397-407. doi: 10.1016/j.encep.2010.01.004. Epub 2010 Mar 11.

引用本文的文献

1
Schizophrenia and Bone Marrow Disorders: An Emerging Clinical Association.精神分裂症与骨髓疾病:一种新出现的临床关联
Cureus. 2024 Dec 16;16(12):e75822. doi: 10.7759/cureus.75822. eCollection 2024 Dec.
2
NMDA receptor modulation by Esculetin: Investigating behavioral, biochemical and neurochemical effects in schizophrenic mice model.七叶亭对NMDA受体的调节作用:对精神分裂症小鼠模型行为、生化和神经化学效应的研究
Saudi Pharm J. 2024 Apr;32(4):101994. doi: 10.1016/j.jsps.2024.101994. Epub 2024 Feb 15.
3
Risk and protective factors of relapse in patients with first-episode schizophrenia from perspectives of health professionals: a qualitative study in northeastern Thailand.

本文引用的文献

1
Schizophrenia: Basic and Clinical.精神分裂症:基础与临床
Adv Neurobiol. 2017;15:255-280. doi: 10.1007/978-3-319-57193-5_9.
2
Lay beliefs about the causes and cures of schizophrenia.关于精神分裂症病因和治疗方法的迷信观念。
Int J Soc Psychiatry. 2017 Sep;63(6):518-524. doi: 10.1177/0020764017717283. Epub 2017 Jun 29.
3
Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations.帮助精神分裂症患者戒烟:特殊考量
从卫生专业人员的角度来看首发精神分裂症患者复发的风险和保护因素:泰国东北部的一项定性研究。
F1000Res. 2021 Jun 25;10:499. doi: 10.12688/f1000research.53317.1. eCollection 2021.
4
Neural Substrates of the Drift-Diffusion Model in Brain Disorders.脑部疾病中漂移扩散模型的神经基质
Front Comput Neurosci. 2022 Jan 7;15:678232. doi: 10.3389/fncom.2021.678232. eCollection 2021.
5
Stem cell-based models and therapies: a key approach into schizophrenia treatment.基于干细胞的模型和疗法:治疗精神分裂症的关键方法。
Cell Tissue Bank. 2021 Jun;22(2):207-223. doi: 10.1007/s10561-020-09888-3. Epub 2021 Jan 2.
6
Regulation of Reactive Oxygen Species-Mediated Damage in the Pathogenesis of Schizophrenia.精神分裂症发病机制中活性氧介导的损伤调控
Brain Sci. 2020 Oct 16;10(10):742. doi: 10.3390/brainsci10100742.
7
Medication Profile and Treatment Cost Estimation Among Outpatients with Schizophrenia, Bipolar Disorder, Depression, and Anxiety Disorders in Indonesia.印度尼西亚精神分裂症、双相情感障碍、抑郁症和焦虑症门诊患者的用药情况及治疗成本估算
Neuropsychiatr Dis Treat. 2020 Mar 26;16:815-828. doi: 10.2147/NDT.S240058. eCollection 2020.
CNS Drugs. 2017 Jun;31(6):471-481. doi: 10.1007/s40263-017-0438-8.
4
The relationship between internalized stigma and quality of life among people with mental illness: are self-esteem and sense of coherence sequential mediators?精神疾病患者内化耻辱感与生活质量之间的关系:自尊和连贯感是序贯中介变量吗?
Qual Life Res. 2017 Sep;26(9):2471-2478. doi: 10.1007/s11136-017-1596-3. Epub 2017 May 22.
5
The impact of genetics on future drug discovery in schizophrenia.遗传学对精神分裂症未来药物研发的影响。
Expert Opin Drug Discov. 2017 Jul;12(7):673-686. doi: 10.1080/17460441.2017.1324419. Epub 2017 May 18.
6
Interactions between cannabis and schizophrenia in humans and rodents.大麻与人类和啮齿动物精神分裂症之间的相互作用。
Rev Neurosci. 2017 Oct 26;28(7):811-823. doi: 10.1515/revneuro-2016-0083.
7
Evidence for differential opioid use disorder in schizophrenia in an addiction treatment population.在一个成瘾治疗人群中,精神分裂症中阿片类药物使用障碍的证据存在差异。
Schizophr Res. 2018 Apr;194:26-31. doi: 10.1016/j.schres.2017.05.004. Epub 2017 May 6.
8
Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?改良地中海饮食以富集短链脂肪酸:对精神分裂症的免疫和代谢功能障碍而言是否具有潜在辅助治疗作用?
Front Neurosci. 2017 Mar 27;11:155. doi: 10.3389/fnins.2017.00155. eCollection 2017.
9
Comparative study of clozapine versus risperidone in treatment-naive, first-episode schizophrenia: A pilot study.氯氮平与利培酮治疗初发、首发精神分裂症的对照研究:一项初步研究。
Indian J Med Res. 2016 Nov;144(5):697-703. doi: 10.4103/ijmr.IJMR_279_15.
10
Experiences of stigma and discrimination faced by family caregivers of people with schizophrenia in India.印度精神分裂症患者家属所经历的污名化和歧视。
Soc Sci Med. 2017 Apr;178:66-77. doi: 10.1016/j.socscimed.2017.01.061. Epub 2017 Feb 1.